Net Income (Loss) Per Share

12 Months Ended

Dec. 31, 2021

The following table sets forth the computation of basic and diluted net income (loss) per share attributable to common stockholders for the years ended December 31, 2021, 2020 and 2019 (in thousands,except share and per share data):


	Year Ended December 31,
	2021		2020		2019
BASIC EPS
Numerator:
Net income (loss)	$	35,446	$	(125,187)	$	119,040
Less:
Income attributable to convertible preferred stock	(3,209)		—		(39,500)
Income attributable to options exercises by promissory notes	(387)		—		(1,088)
Income attributable to unvested early exercised options	(95)		—		(39)
Income attributable to unvested RSA's	(52)		—		(2,037)
Net income (loss) attributable to common stock	$	31,703	$	(125,187)	$	76,376
Denominator:
Weighted-average shares used in computing net income (loss) per share: Basic	324,836,076		214,936,545		210,937,147
Net income (loss) per share attributable to common stock: Basic	$	0.10	$	(0.58)	$	0.36
DILUTED EPS
Numerator:
Net income (loss)	$	35,446	$	(125,187)	$	119,040
Less:
Income attributable to convertible preferred stock	(3,058)		—		(39,329)
Income attributable to options exercises by promissory notes	(369)		—		(1,083)
Income attributable to unvested early exercised options	(91)		—		(39)
Income attributable to unvested RSA's	(49)		—		(2,028)
Net income (loss) attributable to common stock	$	31,879	$	(125,187)	$	76,561
Denominator:
Weighted-average shares used in computing net income (loss) per share: Basic	324,836,076		214,936,545		210,937,147
Weighted-average dilutive stock options, RSUs, and convertible security	17,927,556		—		1,428,282
Weighted-average shares used in computing net income (loss) per share: Diluted	342,763,632		214,936,545		212,365,429
Net income (loss) per share attributable to common stock: Diluted	$	0.09	$	(0.58)	$	0.36

The following table presents the forms of antidilutive potential common shares:


	Year Ended Year Ended December 31,
	2021	2020	2019
Convertible preferred stock	—	109,090,908	109,090,908
Stock options exercised for promissory notes	2,884,999	8,022,499	5,760,000
Early exercised stock options	487,000	19,800	11,337
Unvested RSAs	181,737	1,236,771	3,924,414
Stock options	—	20,754,985	7,439,700
Unvested RSU	291,093	—	—
ESPP	246,246	—	—
Total antidilutive potential common shares	4,091,075	139,124,963	126,226,359

The table above does not include the convertible security issued in 2020. The sellers converted the convertible security in 2021 following the completion of the Company's IPO.